GeneCentric Secures $2,500,000 Series A Round

  • Feed Type
  • Date
    7/5/2013
  • Company Name
    GeneCentric
  • Mailing Address
    280 S. Mangum Street Durham, NC 27701 USA
  • Company Description
    The mission of GeneCentric Diagnostics is to develop and commercialize novel molecular diagnostic assays that enable oncologists and their patients make more informed, individualized treatment decisions.
  • Website
    http://www.genecentric.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $2,500,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    The company will use the Series A financing to continue advancing diagnostic technologies in oncology, according to co-founder and Chief Executive Myla Lai-Goldman.
  • M&A Terms
  • Venture Investor

Trending on Xconomy